FDA UDI
In Commercial Distribution
🇺🇸 United States
Genio System 2.1
DI: 05404031024847
·
Model: Genio Activation Chip Model #2364
·
Nyxoah
Product Codes
1
GMDN Terms
1
Identifiers
1
Pkg Device Count
1
Basic Information
- Brand Name
- Genio System 2.1
- Primary DI
- 05404031024847
- Version / Model
- Genio Activation Chip Model #2364
- Catalog Number
- NX-PKG-002484
- Company Name
- Nyxoah
- Labeler DUNS
- 400460590
- Distribution Status
- In Commercial Distribution
- Device Count in Pkg
- 1
- Record Status
- Published
- Publish Date
- 2025-08-26
- Public Version
- 1
- Public Version Date
- 2025-09-03
- Public Version Status
- New
- Public Device Record Key
- 42b18358-476f-42e7-b7a2-f350b81c1352
Device Description
The Activation Chip is the power source for the Implantable Stimulator. The Activation Chip contains a rechargeable battery, electronics for Bluetooth communication and electromagnetic power transmission, and a microprocessor that stores the user-specific stimulation parameters. The Activation Chip must be connected to the Disposable Patch and placed on the chin each night for stimulation to be delivered, and the battery must be recharged daily.
Device Characteristics
- Single Use
- No
- Prescription Use (Rx)
- Yes
- Over the Counter (OTC)
- No
- Kit
- No
- Combination Product
- No
- HCT/P
- No
- Contains NRL
- No
- Not Made with NRL
- No
- MRI Safety
- Labeling does not contain MRI Safety Information
- Direct Marking Exempt
- No
- PM Exempt
- No
- Has Serial Number
- Yes
- Has Lot/Batch Number
- No
- Has Manufacturing Date
- Yes
- Has Expiration Date
- No
- Has Donation ID
- No
Sterilization
- Is Sterile
- No
- Sterilization Prior Use
- No
Product Codes
| Code | Name | Medical Specialty | Regulation # | Device Class |
|---|---|---|---|---|
| MNQ | Stimulator, Hypoglossal Nerve, Implanted, Apnea | Unknown | 3 |
GMDN Terms
| Code | Name | Definition | Implantable | Status |
|---|---|---|---|---|
| 60360 | Implantable sleep apnoea treatment system, fixed-rate | An assembly of devices intended for home management of obstructive sleep apnoea (OSA) using an implanted stimulator to provide fixed-rate electrical stimulation to the hypoglossal nerve [targeted hypoglossal nerve stimulation (THN)]. It may take two forms: 1) an implanted pulse generator with implanted lead and electrode cuff with a portable patient-operated remote controller/charger; or 2) an unpowered stimulator with paddle electrodes with an external battery-powered control unit which supplies power telemetrically to the implant. It will include dedicated application software used by a healthcare professional for device configuration. | Yes | Active |
Identifiers
| Type | ID | Issuing Agency | Package Type | Qty per Pkg | Pkg Status | Pkg Discontinue Date |
|---|---|---|---|---|---|---|
| Primary | 05404031024847 | GS1 |
Premarket Submissions
| Submission Number | Supplement Number |
|---|---|
| P240024 | 000 |